Identifying Patients with Bicuspid Aortic Valve Disease in UK Primary Care: A Case-Control Study and Prediction Model

William Evans1, Ralph Kwame Akyea1, Stephen Weng2

  • 1Primary Care Stratified Medicine (PRISM), Centre for Academic Primary Care, School of Medicine, University of Nottingham, Nottingham NG7 2RD, UK.

Insights

Bicuspid aortic valve disease (BAV), the most common congenital heart defect, can be suspected in patients experiencing palpitations, atrial fibrillation (AF), or hypertension. Early detection via echocardiography is crucial for improved patient outcomes.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Epidemiology

Background:

  • Bicuspid aortic valve disease (BAV) is the most prevalent congenital heart anomaly.
  • Early identification of BAV is critical for enhancing patient prognosis and management.
  • Current diagnostic pathways may benefit from improved strategies for timely BAV detection.

Purpose of the Study:

  • To identify clinical features associated with BAV diagnosis in primary care.
  • To assess the prevalence of BAV within a large UK primary care database.
  • To develop a predictive model for BAV to aid in patient stratification for echocardiography screening.

Main Methods:

  • A case-control study utilizing the Clinical Practice Research Datalink (CPRD) electronic health records.
  • Propensity-score matching was employed to select up to five controls for each BAV case.
  • Multivariable regression analysis was used to identify significant clinical predictors of BAV.

Main Results:

  • The study identified 2,898 cases of BAV, with a prevalence of 1 in 5,181 in the CPRD, lower than anticipated.
  • Key clinical features associated with BAV included palpitations (OR: 2.86), atrial fibrillation (AF) (OR: 2.25), and hypertension (OR: 1.72).
  • The developed prediction model achieved an AUC of 0.669, with a PPV of 5.9% and NPV of 99% at 1% population prevalence.

Conclusions:

  • Palpitations, hypertension, and AF should raise clinical suspicion for BAV, warranting echocardiographic evaluation.
  • The findings support the development of a predictive model to identify patients who may benefit from echocardiography screening for BAV.
  • Improved diagnostic and recording practices are suggested to enhance BAV detection rates.